Mirtazapine Tablet, Film Coated
Product Images NDC 71610-523

3 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 71610-523). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 30 mg (71610 0523 30)

Bottle Label 30 mg (71610 0523 30)
Packaging label for Mirtazapine 30 mg film-coated tablets. The label includes storage instructions and indicates the product is manufactured by AlphaPharma Pty Ltd and repackaged by Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN. It shows the product NDC 71610-0523-30 and states the package contains 30 tablets for oral use, prescription only.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Mirtazapine Structural Formula (Image 04)

Mirtazapine Structural Formula (Image 04)
Chemical structure diagram of mirtazapine, showing the arrangement of its rings and atoms in the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.